covid-19 vaccine infection Coronavirus

Pfizer identifies lead coronavirus drug candidate

Reading now: 166
www.pharmaceutical-technology.com

Pfizer has announced progress in its research programme to develop antivirals and vaccine for the Covid-19 coronavirus infection.

The company identified a lead drug candidate. According to findings from initial screening assays, analogues of the compound are potent SARS-CoV-2 3C-like (3CL) protease inhibitors.

Pfizer said that preliminary data revealed antiviral activity of the candidate against the novel coronavirus. The company will conduct pre-clinical confirmatory studies, including anti-viral profiling and suitability for intravenous administration clinically.

Furthermore, the company is making preparations to conduct a clinical study of the lead candidate in the third quarter of this year. Azithromycin review The company is

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA